{"id":"https://openalex.org/W306981328","doi":"https://doi.org/10.1007/s10637-015-0248-0","title":"Generation and tumor recognition properties of two human monoclonal antibodies specific to cell surface anionic phospholipids","display_name":"Generation and tumor recognition properties of two human monoclonal antibodies specific to cell surface anionic phospholipids","publication_year":2015,"publication_date":"2015-05-18","ids":{"openalex":"https://openalex.org/W306981328","doi":"https://doi.org/10.1007/s10637-015-0248-0","mag":"306981328","pmid":"https://pubmed.ncbi.nlm.nih.gov/25983040"},"language":"en","primary_location":{"id":"doi:10.1007/s10637-015-0248-0","doi":"https://doi.org/10.1007/s10637-015-0248-0","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10637-015-0248-0","pdf_url":null,"source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/20.500.11850/101193","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082958811","display_name":"Emil Bujak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I35440088","display_name":"ETH Zurich","ror":"https://ror.org/05a28rw58","country_code":"CH","type":"education","lineage":["https://openalex.org/I2799323385","https://openalex.org/I35440088"]},{"id":"https://openalex.org/I4405256901","display_name":"Institute of Pharmaceutical Sciences","ror":"https://ror.org/04n35qp23","country_code":"CH","type":"facility","lineage":["https://openalex.org/I2799323385","https://openalex.org/I35440088","https://openalex.org/I4405256901"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Emil Bujak","raw_affiliation_strings":["Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Z\u00fcrich, Vladimir-Prelog-Weg 2, CH-8093, Zurich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Z\u00fcrich, Vladimir-Prelog-Weg 2, CH-8093, Zurich, Switzerland","institution_ids":["https://openalex.org/I35440088","https://openalex.org/I4405256901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068909668","display_name":"Francesca Pretto","orcid":"https://orcid.org/0000-0002-4353-9650","observed_orcids":["https://orcid.org/0000-0002-4353-9650"]},"institutions":[{"id":"https://openalex.org/I4210109060","display_name":"Philochem (Switzerland)","ror":"https://ror.org/01hp71z51","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210109060"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Francesca Pretto","raw_affiliation_strings":["Philochem AG, Libernstrasse 3, CH-8112, Otelfingen, Switzerland","Philochem AG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Philochem AG, Libernstrasse 3, CH-8112, Otelfingen, Switzerland","institution_ids":["https://openalex.org/I4210109060"]},{"raw_affiliation_string":"Philochem AG","institution_ids":["https://openalex.org/I4210109060"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020168745","display_name":"Dario Neri","orcid":"https://orcid.org/0000-0001-5234-7370","observed_orcids":["https://orcid.org/0000-0001-5234-7370"]},"institutions":[{"id":"https://openalex.org/I35440088","display_name":"ETH Zurich","ror":"https://ror.org/05a28rw58","country_code":"CH","type":"education","lineage":["https://openalex.org/I2799323385","https://openalex.org/I35440088"]},{"id":"https://openalex.org/I4405256901","display_name":"Institute of Pharmaceutical Sciences","ror":"https://ror.org/04n35qp23","country_code":"CH","type":"facility","lineage":["https://openalex.org/I2799323385","https://openalex.org/I35440088","https://openalex.org/I4405256901"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Dario Neri","raw_affiliation_strings":["Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Z\u00fcrich, Vladimir-Prelog-Weg 2, CH-8093, Zurich, Switzerland","[ETH, Zurich]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Z\u00fcrich, Vladimir-Prelog-Weg 2, CH-8093, Zurich, Switzerland","institution_ids":["https://openalex.org/I35440088","https://openalex.org/I4405256901"]},{"raw_affiliation_string":"[ETH, Zurich]","institution_ids":["https://openalex.org/I35440088"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5020168745"],"corresponding_institution_ids":["https://openalex.org/I35440088","https://openalex.org/I4405256901"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":null,"fwci":0.6767,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.64186482,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"33","issue":"4","first_page":"791","last_page":"800"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8730000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8730000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.01720000058412552,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12672","display_name":"Phagocytosis and Immune Regulation","score":0.01119999960064888,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phosphatidylserine","display_name":"phosphatidylserine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/anionic-phospholipids","display_name":"anionic phospholipids","score":0.9549999833106995},{"id":"https://openalex.org/keywords/human-monoclonal-antibodies","display_name":"human monoclonal antibodies","score":0.8320000171661377},{"id":"https://openalex.org/keywords/bavituximab","display_name":"bavituximab","score":0.9739999771118164},{"id":"https://openalex.org/keywords/phosphatidic-acid","display_name":"phosphatidic acid","score":0.8669999837875366},{"id":"https://openalex.org/keywords/cardiolipin","display_name":"cardiolipin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.8550000190734863},{"id":"https://openalex.org/keywords/tumor-accumulation","display_name":"tumor accumulation","score":0.5870000123977661},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.9240000247955322},{"id":"https://openalex.org/keywords/antibody-production","display_name":"antibody production","score":0.35499998927116394}],"concepts":[{"id":"https://openalex.org/C2779637612","wikidata":"https://www.wikidata.org/wiki/Q2354337","display_name":"Phosphatidylserine","level":4,"score":0.8964909911155701},{"id":"https://openalex.org/C2781302388","wikidata":"https://www.wikidata.org/wiki/Q183453","display_name":"Cardiolipin","level":4,"score":0.7220958471298218},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6697756052017212},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6674536466598511},{"id":"https://openalex.org/C2776909261","wikidata":"https://www.wikidata.org/wiki/Q66000256","display_name":"Phosphatidic acid","level":4,"score":0.6155363917350769},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5233842134475708},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.46555832028388977},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.44431376457214355},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3910600244998932},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3669126629829407},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3487926721572876},{"id":"https://openalex.org/C2778918659","wikidata":"https://www.wikidata.org/wiki/Q186915","display_name":"Phospholipid","level":3,"score":0.3267124891281128},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23429372906684875},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002462","descriptor_name":"Cell Membrane","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008809","descriptor_name":"Mice, Inbred C3H","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010743","descriptor_name":"Phospholipids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1007/s10637-015-0248-0","doi":"https://doi.org/10.1007/s10637-015-0248-0","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10637-015-0248-0","pdf_url":null,"source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},{"id":"pmid:25983040","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25983040","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational new drugs","raw_type":"Journal Article"},{"id":"pmh:oai:doc.rero.ch:331460","doi":null,"is_oa":false,"landing_page_url":"http://doc.rero.ch/record/331460/files/10637_2015_Article_248.pdf","pdf_url":"http://doc.rero.ch/record/331460/files/10637_2015_Article_248.pdf","source":{"id":"https://openalex.org/S4306400148","display_name":"reroDoc Digital Library","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":null},{"id":"pmh:oai:www.research-collection.ethz.ch:20.500.11850/101193","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/20.500.11850/101193","pdf_url":null,"source":{"id":"https://openalex.org/S4306402302","display_name":"Repository for Publications and Research Data (ETH Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I35440088","host_organization_name":"ETH Zurich","host_organization_lineage":["https://openalex.org/I35440088"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Investigational new drugs, 33 (4)","raw_type":"info:eu-repo/semantics/article"},{"id":"doi:10.3929/ethz-b-000101193","doi":"https://doi.org/10.3929/ethz-b-000101193","is_oa":true,"landing_page_url":"https://doi.org/10.3929/ethz-b-000101193","pdf_url":null,"source":{"id":"https://openalex.org/S7407051236","display_name":"ETH Z\u00fcrich Research Collection","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"pmh:oai:www.research-collection.ethz.ch:20.500.11850/101193","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/20.500.11850/101193","pdf_url":null,"source":{"id":"https://openalex.org/S4306402302","display_name":"Repository for Publications and Research Data (ETH Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I35440088","host_organization_name":"ETH Zurich","host_organization_lineage":["https://openalex.org/I35440088"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Investigational new drugs, 33 (4)","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W29053622","https://openalex.org/W1490172408","https://openalex.org/W1501982791","https://openalex.org/W1552375346","https://openalex.org/W1586330982","https://openalex.org/W1731655839","https://openalex.org/W1914088945","https://openalex.org/W1965140525","https://openalex.org/W1976984381","https://openalex.org/W1987267004","https://openalex.org/W1992203600","https://openalex.org/W1995472148","https://openalex.org/W2000589601","https://openalex.org/W2006203283","https://openalex.org/W2007958170","https://openalex.org/W2013137776","https://openalex.org/W2017158341","https://openalex.org/W2017745942","https://openalex.org/W2024907000","https://openalex.org/W2026511823","https://openalex.org/W2034982045","https://openalex.org/W2046544357","https://openalex.org/W2050668495","https://openalex.org/W2051053561","https://openalex.org/W2055796980","https://openalex.org/W2056669052","https://openalex.org/W2080580789","https://openalex.org/W2083687192","https://openalex.org/W2099133435","https://openalex.org/W2107492252","https://openalex.org/W2116381459","https://openalex.org/W2116549623","https://openalex.org/W2127506447","https://openalex.org/W2128370488","https://openalex.org/W2133926058","https://openalex.org/W2144186245","https://openalex.org/W2151442561","https://openalex.org/W2154492083","https://openalex.org/W2154680146","https://openalex.org/W2157603089","https://openalex.org/W2158096773","https://openalex.org/W2159653257","https://openalex.org/W2161067284","https://openalex.org/W2163777386","https://openalex.org/W2166000466","https://openalex.org/W2169632112","https://openalex.org/W2171019334","https://openalex.org/W2171446213","https://openalex.org/W2270535152","https://openalex.org/W4233695571"],"related_works":["https://openalex.org/W288027372","https://openalex.org/W2604055285","https://openalex.org/W2613260167","https://openalex.org/W4239568726","https://openalex.org/W1973034884","https://openalex.org/W4401662557","https://openalex.org/W3042932626","https://openalex.org/W2163777386","https://openalex.org/W4240312126","https://openalex.org/W2335422951"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}